Compound medicine for depressurization

A drug and compound technology, applied in the field of drugs for the treatment of hypertension, can solve the problems of many side effects, high price, and side effects of drugs, and achieve the effects of lowering blood pressure, reducing sodium and water retention, and eliminating edema

Inactive Publication Date: 2008-02-27
丁松
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] At present, there are many kinds of drugs for the treatment of high blood pressure. The more commonly used drugs are Nifedin and Fujiang Tablets. Although the existing drugs also have a certain antihypertensive effect, most of them have more side effects, such as headache, flushing, tachycardia, and edema. ,, peptic ulcer, lethargy, mental depression, sexual dysfunction, etc., and some drugs not only have side effects, but also are more expensive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0009] The calcium ion antagonist uses nifedipine, and the content of each tablet is 3-6mg; The content of the patent medicine in the tablet is 5-12.5 mg; the potassium magnesium salt is potassium chloride or potassium magnesium aspartate, and the content of the patent medicine in each tablet is 50-200 mg.

Embodiment 2

[0011] The calcium ion antagonist uses nitrendipine, the content of each tablet is 3-10 mg; the β-receptor blocker uses atenolol, and the content of each tablet is 5-12.5 mg; the diuretic uses hydrochlorothiazide, The content of each tablet is 5-12.5 mg; the potassium magnesium salt is potassium chloride or potassium magnesium aspartate, and the content of each tablet is 50-200 mg.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a compound hypotensive medicament which is prepared by compounding a low dosage of calcium ion antagonist, receptor blocking agent, diuretics, potassium and magnesium salt by a predetermined proportion, each unit of the tablet (65-200mg) contains calcium ion antagonist 3-10mg, beta-receptor blocking agent 3-12. 5mg, diuretics 5-12. 5mg, potassium and magnesium salt 50-20mg.

Description

technical field [0001] The invention relates to a medicine for treating hypertension. Background technique [0002] At present, there are many kinds of drugs for the treatment of high blood pressure. The more commonly used drugs are Nifedin and Fujiang Tablets. Although the existing drugs also have a certain antihypertensive effect, most of them have more side effects, such as headache, flushing, tachycardia, and edema. ,, peptic ulcer, lethargy, mental depression, sexual dysfunction, etc., and some drugs not only have side effects, but also are more expensive. Contents of the invention [0003] The purpose of the present invention is to design a low-dose compound medicine to reduce dosage, reduce side effects and improve therapeutic effect. [0004] The technical scheme of the present invention is: a compound antihypertensive drug, which is composed of a small dose of calcium ion antagonist, a small dose of receptor blocker, a small dose of diuretic, a small dose of pota...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/06A61K31/5415A61K33/14A61P9/12A61K31/165A61K31/198A61K31/4422
Inventor 丁松
Owner 丁松
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap